JPWO2023154302A5 - - Google Patents

Info

Publication number
JPWO2023154302A5
JPWO2023154302A5 JP2024546370A JP2024546370A JPWO2023154302A5 JP WO2023154302 A5 JPWO2023154302 A5 JP WO2023154302A5 JP 2024546370 A JP2024546370 A JP 2024546370A JP 2024546370 A JP2024546370 A JP 2024546370A JP WO2023154302 A5 JPWO2023154302 A5 JP WO2023154302A5
Authority
JP
Japan
Prior art keywords
alkyldiyl
peg
alkyl
compound
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024546370A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507316A5 (https=
JP2025507316A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012571 external-priority patent/WO2023154302A1/en
Publication of JP2025507316A publication Critical patent/JP2025507316A/ja
Publication of JPWO2023154302A5 publication Critical patent/JPWO2023154302A5/ja
Publication of JP2025507316A5 publication Critical patent/JP2025507316A5/ja
Pending legal-status Critical Current

Links

JP2024546370A 2022-02-09 2023-02-08 高分子支持8-スルホニル-ベンザゼピン化合物及びそれらの使用 Pending JP2025507316A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263308268P 2022-02-09 2022-02-09
US63/308,268 2022-02-09
PCT/US2023/012571 WO2023154302A1 (en) 2022-02-09 2023-02-08 Macromolecule-supported 8-sulfonyl-benzazepine compounds and their uses

Publications (3)

Publication Number Publication Date
JP2025507316A JP2025507316A (ja) 2025-03-18
JPWO2023154302A5 true JPWO2023154302A5 (https=) 2026-02-12
JP2025507316A5 JP2025507316A5 (https=) 2026-02-12

Family

ID=85778913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546370A Pending JP2025507316A (ja) 2022-02-09 2023-02-08 高分子支持8-スルホニル-ベンザゼピン化合物及びそれらの使用

Country Status (9)

Country Link
US (1) US20250145575A1 (https=)
EP (1) EP4475892A1 (https=)
JP (1) JP2025507316A (https=)
KR (1) KR20240146049A (https=)
CN (1) CN118843480A (https=)
AU (1) AU2023216955A1 (https=)
CA (1) CA3243675A1 (https=)
IL (1) IL314757A (https=)
WO (1) WO2023154302A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233835B1 (en) * 2014-12-18 2019-01-23 F.Hoffmann-La Roche Ag Benzazepine sulfonamide compounds
CN108055842B (zh) * 2015-09-17 2021-06-29 豪夫迈·罗氏有限公司 亚磺酰基苯基或磺亚胺酰基苯基苯并氮杂䓬
EP3464274B1 (en) * 2016-05-23 2020-05-27 H. Hoffnabb-La Roche Ag Benzazepine dicarboxamide compounds with secondary amide function
AU2019337654A1 (en) * 2018-09-12 2021-04-08 Silverback Therapeutics, Inc. Substituted benzazepine compounds, conjugates, and uses thereof
AU2020291014B2 (en) * 2019-06-13 2025-06-05 Bolt Biotherapeutics, Inc. Aminobenzazepine compounds, immunoconjugates, and uses thereof
WO2020252254A1 (en) * 2019-06-13 2020-12-17 Bolt Biotherapeutics, Inc. Macromolecule-supported aminobenzazepine compounds
JP2022549510A (ja) * 2019-09-30 2022-11-25 ボルト バイオセラピューティクス、インコーポレーテッド アミド結合したアミノベンズアゼピン免疫複合体、及びその使用
CN115996756A (zh) * 2020-05-08 2023-04-21 博尔特生物治疗药物有限公司 弹性蛋白酶底物肽连接子免疫缀合物及其用途

Similar Documents

Publication Publication Date Title
CA2462085C (en) Cytotoxic agents
JP5944836B2 (ja) 高分子薬物送達結合体ならびにその製造および使用方法
WO2023131219A1 (en) Conjugates, compositions and methods of use
AU2016347724B2 (en) Novel cryptophycin compounds and conjugates, their preparation and their therapeutic use
KR960000234A (ko) 메틸트리티오 항암제의 부형제-약물 컨쥬게이트, 이를 함유하는 제약학적 조성물 및 이의 제조 방법
JP6957629B2 (ja) 非線状自壊性リンカーおよびそのコンジュゲート
KR102905133B1 (ko) Pegmema 및 약물 함유성 폴리머 세그먼트로 구성된 자가-조립된 다이블록 코폴리머
JPWO2020252294A5 (https=)
JPWO2021226440A5 (https=)
CN120826407A (zh) 包含曲贝替定和芦比替定衍生物的抗体药物偶联物
JPWO2021067242A5 (https=)
JP5105166B2 (ja) ポリエーテルの製造方法
US20090325894A1 (en) Tetracyclic anthraquinones possessing anti-cancer properties
JPWO2021081407A5 (https=)
JPWO2023154302A5 (https=)
JPWO2022272039A5 (https=)
JPWO2021225892A5 (https=)
CN113710323B (zh) 偶联物及癌治疗剂
JPWO2023154307A5 (https=)
JPWO2021046112A5 (https=)
JPWO2022125904A5 (https=)
JPWO2022204536A5 (https=)
AU2015355965B2 (en) Novel PEG derivative
JPWO2022125915A5 (https=)
JPWO2021081402A5 (https=)